Silicate-based bioactive glasses exhibit bone-bonding properties due to the formation of a hydroxy-carbonate apatite (HCA) layer at the glass surface on its contact with living tissues.
Introduction
When implanted in the human body, primarily for maxillofacial/periodontal grafting, bioactive glasses (BGs) naturally integrate with the tissue by a surface-layer of hydroxy-carbonate apatite (HCA) that grows from an amorphous calcium phosphate (ACP) precursor phase. [1] [2] [3] Such silicatebased glasses may be prepared by a traditional melt-quench, 1 sol-gel 3 or evaporation-induced selfassembly (EISA) 4, 5 techniques. While both the sol-gel/EISA routes yield porous structures associated with large surface areas, the EISA-derived mesoporous bioactive glasses (MBGs) 5-8 feature ordered mesoporous networks that is believed to accelerate the HCA formation rate, i.e., the "bioactivity" of the material. [5] [6] [7] Several MBGs of the CaO-SiO 2 -P 2 O 5 system with variable compositions and textural properties are reported, [5] [6] [7] [8] [9] [10] including hierarchically structured meso/macro-porous scaffolds. [11] [12] [13] The "in vitro bioactivity" of a given (M)BG specimen is normally evaluated by monitoring the onset of HCA formation, and qualitatively assessing the amount thereof when the biomaterial is immersed in a simulated body fluid (SBF) for progressively increased intervals. The widely exploited traditional HCA-detection techniques of powder X-ray diffraction (PXRD), Fourier transform infrared spectroscopy (FTIR), scanning or transmission electron microscopy (SEM/TEM) 1, 3, 5, 7-9, 14-17 are more recently complemented by solid-state nuclear magnetic resonance (NMR) spectroscopy. [18] [19] [20] [21] [22] [23] [24] Such studies are often complemented by measuring the concentrations of Ca, P, and Si in the solution after the SBF-exposure of the (M)BG; this typically reveals an initial elevation of the Ca and P concentrations (stemming from the (M)BG dissolution), followed by their reduction during the subsequent ACP/HCA formation processes. However, existing reports on HCA growth are qualitative rather than quantitative.
We recently demonstrated that the relative amounts of the ACP/HCA components of the biomimetic calcium phosphate layer may be quantified either by utilizing solid-state 31 P NMR 22, 23 or PXRD, 23 thereby providing a direct assessment of the extent of ACP→HCA conversion. Herein, we further show that direct quantifications of the relative HCA/ACP contents out of all solid components are accessible. These new quantification procedures for the HCA formation are noninvasive and representative for the entire (solid) sample. Here they are applied for assessing the relative in vitro bioactivities of three MBGs of distinct compositions and textural properties: 7, 9 "S58" (37CaO-58SiO 2 -5P 2 O 5 ), "S85" (10CaO-85SiO 2 -5P 2 O 5 ), and "S90" (10CaO-90SiO 2 ), where each sample is labeled according to its nominal SiO 2 content in mol%. We evaluated the HCA growth across a wide range of SBF-immersion periods from 15 minutes to 30 days.
Note that the in vitro bioactivity of each S58, S85, and S90 composition has been assessed earlier in several reports. 7-9, 22, 23, 25, 26 However, most of them were only of qualitative nature and moreover involved high MBG-loadings per SBF unit volume (3-20 g/L): as discussed by Gunawidjaja et al., 23 bioactivity assessments at such high concentrations may yield very misleading results and-depending on the cation-composition of the MBG-may even quench the HCA formation.
Consequently, the present study that utilized a markedly lower MBG concentration of 0.6 g/L provides the first direct and quantitative probing of the dependence of the HCA formation on the MBG composition. We discuss the present findings in relation to previous ones, 5-7, 9, 23 and provide a set of general recommendations useful for future in vitro bioactivity-testing of biomaterials.
Materials and Methods

MBG Preparation
An EISA procedure 4 was employed to prepare three MBG specimens of nominal molar compositions 10CaO-90SiO 2 , 10CaO-85SiO 2 -5P 2 O 5 , and 37CaO-58SiO 2 -5P 2 O 5 (see Table 1 ). Each of Si, P, and Ca was incorporated by using precursors of tetraethyl orthosilicate (TEOS), triethyl phosphate (TEP) and Ca(NO 3 ) 2 ·4H 2 O, respectively. The MBG synthesis was performed at 40 • C, using the 4 non ionic P123 triblock copolymer as structure-directing agent and other conditions as described in detail in ref. 7 The resulting homogeneous membranes were heated at 700 • C for 6 h to remove organic species and nitrate ions.
In Vitro Studies and Composition Analyses
An SBF solution was prepared according to Kokubo et al. 27 by dissolving NaCl, KCl, NaHCO 3 ,
and Na 2 SO 4 into distilled water. It was buffered at pH=7.38 by using tris(hydroxymethyl)-aminomethane/HCl (TRIS/HCl) and subsequently passed through 0.22 µm Millipore filters to avoid bacterial contamination. 600 mg of each pristine MBG sample in the form of a fine powder (<20 µm particles) was immersed in 1.000 L of SBF in a sealed polyethylene container placed in an Ecotron HT incubator. The solutions were stirred continuously (100 rpm) at 37 • C for variable intervals between 15 minutes and 30 days. After SBF immersion, each solid phase was retained by filtration, soaked in acetone to quench the surface reactions and washed with water, after which it was vacuum-dried at 37 • C for several days. The SBF-soaked specimens will be denoted S90-τ SBF , S85-τ SBF , and S58-τ SBF , with the immersion period τ SBF specified either in hours (h) or days (d).
The solution accompanying each solid MBG-τ SBF phase was analyzed as follows: the pH value was determined as the average of three measurements by using an Ilyte system with ion-selective electrodes specific for Na + , K + , and Ca 2+ . The concentrations of Si, Ca, and P were analyzed by inductively coupled plasma/optical emission spectrometry (ICP/OES) with a Perkin Elmer OPTIMA 3300 DV instrument. Three analyses were performed per solution and element, from which each average value and standard deviation were calculated.
The cation composition of each pristine S90, S85, and S58 MBG specimen was determined by X-ray fluorescence (XRF) spectroscopy, using a Philips PANalytical AXIOS spectrometer (Philips Electronics NV), and X-rays generated by the Rh K α line at λ=61.4 pm. The as-analyzed weight percentages of the (Si, Ca, P) elements were converted into the charge-balanced stoichiometric compositions listed in Table 1 . The minor hydrogen content of each specimen was not accounted for; it mainly consists of physisorbed water molecules and to a lesser extent silanol (SiOH) surface groups. 22, 26, 28 Except for some losses of P, an overall good agreement was observed between the batched and analyzed compositions, as well as with our previously reported results from MBG samples of nominally identical compositions and preparation conditions. 23, 26 However, while the corresponding XRF analyses of the SBF-exposed samples appeared to be reliable for short immersion intervals up to a few hours (as assessed against other constraints from 31 P NMR and the ICP/OES-determined cation concentrations of the accompanying solutions), systematic errors in the XRF-analyses of the solid phases were evident for τ SBF 24 h. Consequently, a more reliable estimate of each MBG-τ SBF composition was obtained as follows: the ICP/OES-determined stoichiometric amounts of Si, Ca, and P present in the accompanying solution at the given immersion interval were combined with the XRF-analyzed cation contents of the corresponding pristine MBG specimens listed in Table 1 ; this information together with eq. (2) allowed us to determine the stoichiometric composition of the solid MBG-τ SBF phase.
Powder X-ray Diffraction
Powder X-ray diffraction (PXRD) patterns were recorded with Cu K α radiation (λ=154.1 pm), using a PANalytical X'Pert PRO MPD diffractometer equipped with an X'Celerator detector. The powders were dispersed on zero-background Si plates and the diffractograms were collected using variable slits and 4 cm 2 irradiated area in the 2θ-range of 10-80 • for a total time of 12 h.
The fractions of crystalline HCA present in the SBF-exposed S58/S85/S90 samples were estimated by using the Rietveld method and the FullProf program, 29 and assuming that the in vitro-formed nanocrystalline HCA phase (here labeled "α") conforms to the ideal stoichiometric calcium hydroxyapatite composition, Ca 5 (PO 4 ) 3 (OH). The apparent weight fraction of HCA (w α ) was obtained by dividing refined scale factors for the samples by that of a crystalline HAp reference sample, denoted "HAref ", which was purchased from Aldrich and used as received. These apparent fractions were then corrected according to ref. 30 , in order to account for the distinct X-ray mass absorption coefficient of HAp [A α ≡ (µ/ρ) α ] and that of the remaining amorphous phases (β) of the sample [A β ≡ (µ/ρ) β ], where µ denotes the linear absorption coefficient and ρ is the density of the sample:
The weight fractions obey w α +w β =1. Table 1 ). The pH then stays relatively constant throughout the remaining of the soaking period, except for a decrease observed beyond ≈24-72 h, which however is only significant for the S85 series.
Figures 1(b, d, f) plot the concentrations of Si, Ca, and P, whereas (c, e, g) display the respective fraction of the total amount of each element present in the solution after the soaking [y soln (E)], with the remaining partitioned among two heterogeneous solid phases, i.e., the ion-leached MBG and the biomimetic phosphate layer:
Here n soln E (τ SBF ) is the as-analyzed stoichiometric amount of element E present in the solution after the soaking interval τ SBF , whereas n SBF E (τ SBF =0) and n MBG After around 1 week, the solutions associated with the soaking of S90 and S85 feature a lower [Ca] than the value of the initial SBF [ Fig. 1(d) ], while the concentration during the immersion of S58 consistently remain above that at τ SBF =0.
Concerning the SBF immersion of the Ca-poor S85/S90 specimens, the trends observed for [P] in Figs For the solutions resulting from immersion of the Ca-rich S58 MBG, the trends for P in Fig. 1(f,   g ) differ markedly from those of Ca in Fig. 1(d, e) : for all intervals τ SBF >0, a lower P concentration is observed relative to that in the initial SBF solution, suggesting that although the S58 structure leaches Ca 2+ rapidly during the first 15 minutes, there is nevertheless a net uptake of phosphate ions into the S58-τ SBF solid phases. This must imply a minor formation of (presumably) Cadeficient ACP during the first few hours of S58-exposure to the SBF, as opposed to the case of S85
that reveals a concurrent release of both Ca 2+ and PO 3− 4 ions to the solution at the earliest SBFimmersion stages. Nevertheless, between 3 and 30 days, the solutions accompanying each distinct S58/S85/S90-deriving solid phase become continuously depleted in P, which for the S58-τ SBF series implies that the entire P reservoir resides in the solid phase after 30 days; see Fig. 1(g ).
Composition of Each Solid MBG-τ SBF Phase
We now focus on the composition of each solid phase that coexists with the solution at a given τ SBF interval. Figure 2 (a, c, e) plots the respective molar fractions of Si, Ca, and P, normalized such that x Si +x Ca +x P =1. The right panel displays the ratio of the fractions of Si, Ca, and P present in each solid phase at a given SBF-immersion period relative to that of the pristine MBG,
i.e., the ratio x E (MBG-τ SBF )/x E (MBG), where E={Ca, Si, P}: this is henceforth referred to as the "relative uptake of E". hand, the uptake of P occurs stepwise, where x P is almost doubled after 15 minutes, whereupon it remains nearly constant out to 24 h, when it elevates again such that the P content of the S58-1d specimen is ≈2.7 times that of the pristine S58 sample; see Fig. 2 (e, f). The corresponding relative uptake for S85-1d only amounts to ≈1.6. Altogether, after 30 days of immersion, both the S85-30d
and S58-30d solid phases comprise ≈2.5 times higher P content relative to each respective pristine MBG (that for the case of S58-30d implies an effectively lowered value compared with the result at τ SBF =24 h).
Finally considering the limiting molar ratios n Ca /n P of Ca and P in each MBG-stemming sample at the longest immersion intervals τ SBF 7 days shown in Fig. 2(g) , they amount to ≈1.8 (for S90), ≈1.5-1.7 (S85), and ≈1.6-1.85 (S58). Noteworthy, these values scatter around the stoichiometric ratio expected for hydroxyapatite (n Ca /n P =1.667), although it is only for the S90/S85-deriving samples-which initially exhibited a nearly complete release of both Ca and P for short τ SBF periods-where these n Ca /n P -values translate directly into the corresponding compositions of the biomimetic phosphate layer. While no significant changes occur in the 31 P NMR peak maxima throughout the SBF exposure, a pronounced peak-narrowing results when τ SBF is increased (Fig. 4 and S1) , signifying the concurrent growth of an ordered phosphate phase, i.e., nano-crystalline HCA. Hence, each 31 P
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NMR response stems from two distinct 31 P sources of the SBF-treated specimens: one ordered phase (HCA) coexisting with an amorphous counterpart. For τ SBF 8 h, the latter derives exclusively from the ACP component of the biomimetic calcium (ortho)phosphate layer in the cases of the S85 and S90 specimens, whose structures were completely depleted in Ca and P over the first 4 h of soaking (see Figs. 1 and 2) . In contrast, for the series of SBF-soaked S58 samples, nonnegligible amounts of CaP clusters remain in the MBG that also contributes to the 31 P resonances in Fig. 4(a) . Owing to the nearly identical 31 P NMR responses of the CaP clusters and biomimetic ACP, 22, 25 these two amorphous calcium phosphate components cannot be probed separately by NMR. While revealing markedly more ordered orthophosphate environments than its ACP counterpart, the biomimetic apatite phase remains nano-crystalline and is known to exhibit structural disorder from the incorporation of additional ion species, such as Na + , Mg 2+ , and CO 
Quantifying the HCA/ACP Components
Relative ACP/HCA Fractions
We first consider the relative amount of each co-existing HCA and ACP component of the biomimetic calcium phosphate layer, as assessed independently by 31 P MAS NMR and PXRD for each SBF-exposed MBG specimen. Consequently, each 31 P NMR peak was deconvoluted into two signals, one from ACP (broad) and one from HCA (narrow). The procedure is described in detail in our previous work 22, 23, 25 and Fig. S1 of the ESI displays each experimental NMR spectrum together with the best-fit peak components. As described in the Materials and Methods section, the PXRD data of Fig. 3 were employed to estimate the weight-fraction [eq.
(1)] of HCA in each MBG-τ SBF specimen. Subsequently, the partitioning of P in the crystalline (HCA) and amorphous (ACP) portions of the samples were derived. We assumed that all remainings of P not present in the ordered HCA phase resides in the ACP counterpart for the S90-τ SBF and S85-τ SBF series of specimens that evidenced an essentially complete leaching of Ca and P already during the earliest stages of the SBF immersion (τ SBF 4 h; see Fig. 2 ) that occurred well before the onset of HCA crystallization (see Fig. 3 ). However, this assumption does not hold for the S58-τ SBF samples where a significant P fraction remains in the CaP clusters of the MBG pore-walls: while we for brevity/simplicity onwards use the label "ACP" in the Figure legends and the following text, it should be remembered that our reported fractions of "ACP" in the S58-τ SBF specimens stem from two amorphous components, whose individual Ca and P contents are not readily disentangled.
The resulting molar fractions of HCA (x HCA ) and ACP (x ACP ) obtained from either 31 The longer-term ACP→HCA conversion constitutes the main qualitative discrepancy between the inferences from NMR and XRD. The NMR-derived HCA fractions manifest very similar trends among all three MBG series and SBF-immersion intervals τ SBF 7 days, where ≈55% of the total P content is present in the ordered HCA phase; see Fig. 5(a) . In contrast, the XRD-derived apatite fraction grows continuously as τ SBF is increased, except for the S58-τ SBF series for which an optimum value x HCA ≈ 0.74 is observed for S58-7d, whereupon the relative amount of HCA decreases. This perhaps counterintuitive effect stems from the depletion of phosphate groups in the solution during the later MBG-soaking stages; see Fig. 1(f, g ). Insufficient concentrations of P in the aqueous medium was shown previously to impede the ACP→HCA conversion. 16 Similar observations were made by us in an earlier SBF-soaking study of the same three MBG series as those herein but employing a significantly higher MBG concentration in the aqueous medium 23 (see section 4.2).
Quantitative HCA Contents
Thus far, we discussed the relative HCA/ACP amounts of the MBG surface-associated phosphate layer. We next consider the amount of this layer out of all solid phases (with the remaining primarily constituting the leached MBG), starting with the molar fractions of HCA formed from each S58/S85/S90 series and immersion interval. They constitute the fractions of the (nano)crystalline and amorphous parts of each solid matrix and are available from the PXRD data. Figure 6 plots the molar fraction of HCA out of all phases in each heterogeneous MBG-τ SBF specimen, revealing a progressively increased amount of HCA formed along the series S90<S85<S58. The highest HCA fraction occurs after 30 days, except for S58 (7 days) and amounts to 0.18, 0.25, and 0.41 for the SBF-exposed S90, S85, and S58 specimens, respectively. These fractions relate as 1.00:1.39:2.28.
Identical trends are observed if instead considering the corresponding weight fractions of HCA (not shown). Hence, the in vitro bioactivity enhances concurrently with increasing amounts of Ca and P in each pristine MBG: their Ca contents relate as 1.00:1.64:2.84 for the S90, S85, and S58 specimens, respectively, while the P counterparts are 1.00(S85):1.28(S58). Note, however, that the HCA fraction of each MBG-τ SBF sample also depends implicitly on the degradation degree of the silicate network during the SBF immersion: from Fig. 1(c) follows that ≈39%, ≈27%, and ≈24% of the total Si reservoirs of the S58, S85, and S90 structures have dissolved, respectively, at the τ SBF -value that optimizes the HCA content. If the comparatively higher Si release from the S58 MBG is accounted for (that in the scenario of equal HCA contents among the distinct MBGs would lead to an apparently higher relative HCA fraction out of all S58-associated solid phases), the estimated relative HCA fractions of the S90:S85:S58 series (1.00:1.39:2.28) become 1.00:1.34:1.85.
Consequently, the S58 structure forms a higher amount of HCA than the S85/S90 MBGs and also converts more completely into HCA on SBF exposure.
After having discussed the relative (stoichiometric) amounts of P present in the HCA and ACP phases, respectively (Fig. 5) , and the relative molar content of HCA out of each MBG-τ SBF specimen ( Fig. 6) , we consider the partitioning of P and Ca in the amorphous (ACP) and crystalline (HCA) components of each solid phase. This XRD-derived information is provided in Fig. 7 , which displays the atomic fractions of P (x P ) and Ca (x Ca ) in the top and bottom panels, respectively. Note that x P and x Ca are here defined with respect to all atom species, including oxygen: for a significant reservoir of ACP first being accumulated at τ SBF =8 h prior to the onset of HCA formation (τ SBF =24 h). However, it is likely that analogous trends prevail also during the soaking of the P-bearing S85 and (particularly) S58 specimens. As already commented, the "ACP" phase detected in each S58-τ SBF specimen carries non-negligible contributions from the amorphous CaP clusters of the MBG, while the data of Figs. 1(f, g) and 2(e, f) strongly suggest the presence of significant ACP deposits already after 15 minutes of SBF-exposure.
Discussion
Composition-Bioactivity Trends
Both 31 P MAS NMR and PXRD evidence significant HCA deposits at the surfaces of all three MBG specimens at 24 h of SBF immersion (Fig. 5) . Although the powder diffractograms reveal no signatures of HCA formation before 24 h, already after 8 h the NMR data suggest ≈22% and 9%
of HCA out of the biomimetic calcium phosphate layers at the S90 and S85 surfaces, respectively.
This apparent discrepancy likely stems from poorly ordered nm-sized HCA crystallites that escape detection by XRD. The overall highest XRD-derived HCA fractions are 81% (after 30 days), 69%
(30 days), and 74% (7 days) for the S90, S85, and S58 series, respectively, whereas the corresponding estimates by NMR are all ≈55% for τ SBF 7 d.
Considering the highest observed relative amounts of HCA out of the entire MBG-τ SBF solid phase, the S58-7d specimen reveals 2.28 (1.85) and 1.64 (1.34) times higher HCA contents than its S90-30d and S85-30d counterparts, respectively, where the numbers in parentheses correct for the differences of Si release among the samples; see section 3.4.2 and Figs. 1 and 6 . Consequently, the in vitro bioactivity enhances according to S90<S85<S58, meaning that the amount of HCA correlates with an increase of the Ca and P contents of each pristine MBG (or, equivalently, with decreasing Si content 35, 36 ). Two inferences are noteworthy: (i ) This trend mirrors that established for melt-prepared BGs in that the bioactivity generally enhances when the P content of the glass is increased (up to 6 mol% P 2 O 5 ); 14, 37, 38 the concurrent bioactivity-growth for increasing P content was recently suggested to be monotonic, provided that P is present as readily released orthophosphate ions. 39 The latter condition is obeyed for the MBGs; 26, 28 see Fig. 4. (ii ) Whereas the HCA formation clearly depends on the MBG composition, the mesoporous arrangement and/or the surface area of the MBG ( Table 1 ) correlate neither with the time-point when HCA starts crystallizing nor with the amount of HCA subsequently formed. Incidentally, the highest HCA deposits occur for the S58 specimen associated with lowest surface area (195 m 2 g −1 ). This effect must imply that all parent MBGs exhibit silicate networks exposed sufficiently well to the solution that the precise total surface area becomes immaterial.
Somewhat intriguing, however, is that although the bioactivity trends observed herein overall agree with earlier reports from sol-gel glasses [whose degradation and HCA formation increases (decreases) with the Ca (Si) content 35, 36 ], it differs markedly from those inferred previously for MBGs, [5] [6] [7] [8] [9] 23 where the formation rate of HCA and its amount deposited was maximized for MBGs with ≈80-85 mol% SiO 2 and then decreasing as the SiO 2 content was increased. 5, 7, 8 Besides that previous bioactivity-composition evaluations (as assessed from FTIR and/or electron microscopy)
were of qualitative nature, these apparent discrepancies originate from very different MBG loadings PXRD even over prolonged SBF-exposure intervals up to 7 days, while the 31 P NMR peak-width only revealed an insignificant narrowing. Similar NMR/PXRD responses were observed for the S90 MBG at the high m MBG /V =20 g/L loading (not shown), whereas it did not exhibit the characteristic "peak-splitting" for orthophosphate species in FTIR spectra. 9 Under the same in vitro conditions, the highly bioactive S85 counterpart manifested a markedly delayed onset of HCA formation compared with previous reports that utilized lower MBG concentrations in the bioactivity assessments. 7, 8
The Importance of the Bioactivity Assessment Conditions
The apparently reduced HCA formation at high MBG loadings in the SBF may be understood from an insufficient P reservoir in the aqueous medium, coupled with the large surface area of the mesoporous material: 16 the very rapid leaching of Ca 2+ ions from the powder initiates a substantial ACP formation at the pore-surface due to local supersaturation. Consequently, the entire P content becomes incorporated into the ACP phase, leaving an insufficient number of phosphate ions in the solution to allow for a further ACP growth-and most important-the subsequent ACP→HCA crystallization stage. 16 Note that the effects of the HCA crystallization process from using too high m/V ratios are more detrimental for MBGs than for their melt-prepared BG counterparts that feature significantly lower surface areas and thereby a more limited number of nucleation sites for the ACP/HCA growth. Hence, the inherent advantage of the ordered mesoporous structure then merely becomes a severe shortcoming that may completely alter the outcome of the bioactivity assessment.
Even under the markedly more dilute m MBG /V =0. Although the more dilute conditions the better (except for an infinite dilution when readily dissolved materials will disintegrate completely before HCA is deposited), the obvious drawback with too low m/V -ratios is that an impractically large solution volume is required to produce a large mass of the SBF-exposed solid material ( 200 mg), such as that demanded for the quantitative NMR/XRD analyses employed in the current work.
Conclusions
Solid-state 31 P NMR and PXRD were employed to quantify the relative fractions of ACP and HCA forming at the surfaces of three MBGs of variable Si, Ca, and P contents, thereby allowing for a detailed quantitative insight into the ACP→HCA conversion. The PXRD data together with measured concentrations of Ca, Si and P in the solution was used to estimate the amount of HCA present in each solid specimen after the SBF treatment, as well as the composition of the remaining cation-depleted MBG phase.
Although HCA started forming at equal SBF-immersion intervals (∼24 h) among all three MBGs, the amount of HCA increased concurrently with the Ca and P contents of the MBGs according to S90<S85<S58. This trend is at odds with previous inferences about the in vitro bioactivity from MBGs of similar/identical compositions, 7-9, 22, 23 but was rationalized as stemming from a too high MBG loading in the SBF solution (i.e., too high m/V ratio) employed in previous tests. Notably, the surface areas of the present MBGs are sufficiently large that no correlation was observed between the surface area and the HCA formation rate or/and the resulting amount of HCA.
We highlighted the importance of adapting the m/V ratio to the composition of the biomaterial (vide infra), where the in vitro evaluation must invoke a sufficiently large SBF volume such that its Ca 2+ and PO (g) The molar ratio between Ca and P, n Ca /n P =x Ca /x P . The dotted horizontal line at x Ca /x P =1.67
represents the value for stoichiometric HAp [Ca 5 (PO 4 ) 3 OH]. The error bar of each x E -value and relative uptake are as indicated for the corresponding S85-deriving data set. MBG specimens before and after exposure to SBF for the as-indicated intervals. The NMR peaknarrowing for increasing τ SBF reflects the formation of nano-crystalline HCA. The result from 30 a sample of crystalline hydroxyapatite, "HAref ", is also displayed in (c). Note that since the S90 MBG is devoid of P, all 31 P NMR signals detected from the S90-τ SBF phases stem from the biomimetic phosphate layer. 
